Table 2.
The microbiological causes of central line-associated bloodstream infections
|
Organism
|
Number (percentage out of total 34), n (%)
|
MDR organism, n (%)
|
| Gram negative bacteria | ||
| Acinetobacter | 5 (15) | 3 MDR1 (60) |
| Escherichia coli | 4 (12) | 1 ESBL (25) 2 CRE (50) |
| Pseudomonas | 4 (12) | 2 CRP (50) |
| Klebsiella | 3 (8) | 2 CRE (66) |
| Morganella | 1 (3) | |
| Serratia | 1 (3) | |
| Stenotrophomonas maltophilia | 1 (3) | |
| Total gram negative | 19 (56) | 10 (53) |
| Gram positive bacteria | ||
| Enterococcus | 5 (15) | 3 VRE (60) |
| Coagulase negative Staphylococcus | 6 (18) | 6 MRCONS (100) |
| Staphylococcus aureus | 2 (5) | 1MRSA (50) |
| Streptococcus viridans | 1 (3) | |
| Total gram positive | 14 (41) | 10 (71) |
| Candida species | 1 (3) | |
| Total | 34 (100) | 20/34 (59) |
1
Multi-drug resistance: Resistant to > 3 classes of antimicrobial.
CRE: Carbapenem resistant enterobacteriasae; ESBL: Extended spectrum B lactamase producer; CRP: Carbapenem resistant pseudomonas; VRE: Vancomycin resistant enterococcus; MRCONS: Methicillin resistant coagulase negative staphylococcus; MRSA: Methicillin resistant staphylococcus aureus; MDR: Multi-drug resistance.